Powder Delivery TRIZ Cases

Aerosolized ECM-derived materials act as a biological intermediary to prevent pulmonary fibrosis, avoiding complex surgical interventions.

A soft dough oral delivery system combines ceramides and fatty acids to treat atopic dermatitis in mammals.

Humidity conditioning of co-micronized carrier particles dissipates accumulated electrostatic charges, preventing drug segregation and agglomeration.

A closed mixing vessel combines fluorescent substances with serum albumin to produce NIR-II contrast agents.

A dry powder inhalation formulation combines tiotropium bromide, formoterol fumarate, and mometasone furoate.

Saccharide excipients in the formulation reduce processing time and water content while preserving thrombin stability.

Segmented vegetable-derived lipid layers shield lactic and bifidobacteria from gastric acidity, maintaining intestinal colonization viability.

A probiotic composition combines Bifidobacterium longum, Lactobacillus helveticus, and Lactobacillus plantarum with a carrier containing inulin, fructose, mineral salts, lactoferrin, and glutathione.

Merging gadolinium chelants onto a lysine scaffold boosts image contrast while reducing toxicity from high doses.

A one-piece base body integrates the capsule chamber and duct support to simplify manufacturing.

CT20 peptide binds chaperonin containing TCP to inhibit metastasis in triple-negative breast cancer.

Optimized 100-350 µm microparticles prevent conduit blockages during low-pressure spraying, ensuring reliable bleeding control.

Anthostema senegalense microspheres deliver antiretroviral extracts to inhibit HIV replication while reducing side effects from triple therapies.

Micronized dry powder formulation combines tiotropium, formoterol, and cromolyn derivative for respiratory treatment.

A polysaccharide support with pendant terminal amines reacts with amine-reactive binding pair members to form stable conjugates.

Smectite clay crystallites restore cell adhesion by creating electrostatic bridges, inhibiting cancer metastasis and aiding tissue regeneration.

Optimized N,N-diethylaminoethyl methacrylate ratios enable high loading capacity while preventing active ingredient crystallization.

Standardized valerian, saffron, and L-theanine formulation reduces anxiety and depression side effects.

Lidocaine nanocrystals in medical gel increase bioavailability to resolve delayed pain relief during catheter insertion.

A polyvinyl alcohol coating composition incorporates a fatty acid ester of a polyol to modify surface properties.

Electronic control of direct air and fuel injection eliminates complex valve timing mechanisms, reducing mechanical losses and expanding operational range.

A lipid nanoparticle delivery vehicle uses antibody targeting moieties to bind specific stem cell surface markers for precise therapeutic agent transport.

pH-dependent excipient expansion retains the dosage form in the upper gastrointestinal tract, extending drug release time beyond standard tablet limitations.

Transforming high concentration solutions into discrete particles bypasses solubility thresholds and viscosity issues while maintaining agent stability.

Lyophilized rotavirus vaccine formulation stabilizes viral particles at room temperature, eliminating cold chain storage requirements.

Sugar and bulking stabilizers in dry vaccine formulations preserve live attenuated virus efficacy at room temperature, eliminating cold chain costs.

Self-assembling nanocage fusion proteins display antibodies on their exterior surface to preserve biological activity.

Segmented gel matrices protect multiparticulate opioid beads from crushing, preventing rapid abuse while maintaining therapeutic release.

A freeze-drying method for biologically active proteins using non-polymeric sugars and constrained frozen bodies.

Radiolabeled anti-PD-L1 antibodies replace static biopsy snapshots with dynamic whole-body imaging to resolve heterogeneous expression detection challenges.

Sodium bisulfite and arginine stabilize freeze-dried Omadacycline Tosylate, reducing impurities below 5% after six months at 40°C.

Spray-dried amorphous glass matrices stabilize oxytocin, eliminating refrigeration needs and enabling self-administration in resource-limited settings.

Branched polymeric carriers transport active ingredients via non-specific aggregation without covalent bonds.

Grouping prior studies by billable order codes reduces review time while maintaining diagnostic accuracy.

A polymeric radiation source molecularly bonds radioisotopes to create stable, customizable ophthalmic brachytherapy devices.

Encapsulated faecal composition uses cryoprotectant below 8% to reduce side effects while maintaining microbial viability.

A carrier-free nanoparticle formed by self-assembling a curcumin-erlotinib conjugate targets EGFR-positive tumors.

A polymeric oral composition delivers active ingredients and flavorants through a controlled matrix system.

Polyphosphate stabilizers maintain the amorphous form of calcium carbonate, preventing crystallization to ensure high bioavailability for inhalation therapy.

Direct extrusion feeds powder into a print head, reducing heat load and ensuring consistent composition of 3D printed drug delivery products.

A turmeric pigment composition achieves stable aqueous dispersion through mechanical pulverization in a gum ghatti hydrous solution.

Monodisperse mesoporous silica-supported lipid bilayer nanoparticles overcome in vivo instability and sequestration by maintaining colloidal stability.

A washed platelet extract removes plasma proteins via detergent lysis and centrifugal separation to concentrate growth factors.

Modified hyaluronic acid microspheres embed X-ray opaque contrast agents within a polymer matrix to create uniform, degradable embolic particles.

Intermittent nitric oxide donor administration induces arteriogenesis while the solid formulation prevents volatility degradation.